BRIEF published on 05/13/2024 at 15:50, 1 year 6 months ago Phil Dervan Appointed as Global Partner Strategy Director at Bacula Systems Data Protection Strategic Leadership Phil Dervan Bacula Systems Enterprise Technology
BRIEF published on 05/13/2024 at 15:50, 1 year 6 months ago Phil Dervan nommé directeur de la stratégie mondiale des partenaires chez Bacula Systems Protection Des Données Leadership Stratégique Technologie D'entreprise Phil Dervan Systèmes Bacula
PRESS RELEASE published on 05/13/2024 at 15:45, 1 year 6 months ago Phil Dervan appointed by Bacula Systems as Global Partner Strategy Director Bacula Systems appoints Phil Dervan as Global Partner Strategy Director to strengthen relationships with partners and enhance business growth in response to strong growth in the Americas Recovery Backup Phil Dervan Bacula Systems Leadership Structure
Published on 12/05/2025 at 02:35, 4 hours 43 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 18 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 13 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 18 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 18 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 48 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 28 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 53 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 3 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 4 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 18 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 18 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 33 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 33 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
